Children's cancers, Neuroblastoma
Results
Phase 2
This trial compared high dose chemotherapy with 131-I-mIBG targeted radiotherapy and chemotherapy.
It was for children and young people with neuroblastoma that had:
spread to other parts of the body and
the first hadn’t worked well
The trial was open for people to join between 2018 and 2022. The team reported the results in 2024.
Cancer Research UK supported this trial.
Recruitment start: 1 October 2018
Recruitment end: 28 November 2022
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Guy Makin
Cancer Research UK
Gustave Roussy
University of Birmingham
SIOPEN
This is Cancer Research UK trial number CRUKE/17/017.
Last reviewed: 21 Jan 2025
CRUK internal database number: 15461
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
